Literature DB >> 22116119

USPIO-enhanced MRI of highly invasive and highly metastasizing transplanted human squamous cell carcinoma: an experimental study.

A Tetsumura1, S Nakamura, N Yoshino, H Watanabe, A Kuribayashi, K Nagumo, N Okada, T Sasaki, T Kurabayashi.   

Abstract

OBJECTIVE: The aim of this study was to investigate the signal intensity characteristics of highly invasive and highly metastasizing transplanted human squamous cell carcinoma using ultra-small super-paramagnetic iron oxide (USPIO)-enhanced MRI and to correlate them with USPIO distribution to tumour components revealed by histological examination.
METHODS: 13 nude mice with transplanted human squamous cell carcinoma in the oral cavity were imaged before and 24 hours after intravenous administration of USPIO. The difference in signal intensity between pre-contrast and post-contrast MR images was visually evaluated. For quantitative analysis, signal intensity within a region of interest was measured. Histological findings were correlated with MR findings. The approximate USPIO concentration was evaluated using USPIO phantoms.
RESULTS: Seven tumours had an area showing signal intensity increase on post-contrast T₁ weighted images. Histopathologically, six of those tumours contained a small amount of iron particles in the stroma. The USPIO concentration was presumed low. Two tumours had an area showing signal intensity decrease on post-contrast T₁ and T₂ weighted images. The areas had a large amount of iron particles in the stroma and the USPIO concentration was presumed high. There was a minimal amount of iron particles in tumour parenchymal cells.
CONCLUSIONS: The amount of USPIO accumulation into tumour stroma was considered to affect MR signal intensity. A small amount increases T₁ weighted signal intensity, whereas a large amount decreases T₁ and T₂ weighted intensity. The USPIO accumulation into the tumour parenchyma was not thought to affect MR signal intensity.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22116119      PMCID: PMC3520274          DOI: 10.1259/dmfr/28673011

Source DB:  PubMed          Journal:  Dentomaxillofac Radiol        ISSN: 0250-832X            Impact factor:   2.419


  12 in total

1.  Imaging of macrophages in soft-tissue infection in rats: relationship between ultrasmall superparamagnetic iron oxide dose and MR signal characteristics.

Authors:  Amelie M Lutz; Dominik Weishaupt; Elke Persohn; Kerstin Goepfert; Johannes Froehlich; Bernd Sasse; Jochen Gottschalk; Borut Marincek; Achim H Kaim
Journal:  Radiology       Date:  2005-01-21       Impact factor: 11.105

2.  Ultrasmall superparamagnetic iron oxide: characterization of a new class of contrast agents for MR imaging.

Authors:  R Weissleder; G Elizondo; J Wittenberg; C A Rabito; H H Bengele; L Josephson
Journal:  Radiology       Date:  1990-05       Impact factor: 11.105

3.  Evaluation of tumoral enhancement by superparamagnetic iron oxide particles: comparative studies with ferumoxtran and anionic iron oxide nanoparticles.

Authors:  P-Y Brillet; F Gazeau; A Luciani; B Bessoud; C-A Cuénod; N Siauve; J-N Pons; J Poupon; O Clément
Journal:  Eur Radiol       Date:  2005-02-23       Impact factor: 5.315

4.  Tumoral distribution of long-circulating dextran-coated iron oxide nanoparticles in a rodent model.

Authors:  A Moore; E Marecos; A Bogdanov; R Weissleder
Journal:  Radiology       Date:  2000-02       Impact factor: 11.105

5.  Comparison of two superparamagnetic viral-sized iron oxide particles ferumoxides and ferumoxtran-10 with a gadolinium chelate in imaging intracranial tumors.

Authors:  Peter Varallyay; Gary Nesbit; Leslie L Muldoon; Randal R Nixon; Johnny Delashaw; James I Cohen; Annie Petrillo; Doris Rink; Edward A Neuwelt
Journal:  AJNR Am J Neuroradiol       Date:  2002-04       Impact factor: 3.825

6.  Ferumoxtran-10, a superparamagnetic iron oxide as a magnetic resonance enhancement agent for imaging lymph nodes: a phase 2 dose study.

Authors:  Patricia A Hudgins; Yoshimi Anzai; Marie R Morris; Maria A Lucas
Journal:  AJNR Am J Neuroradiol       Date:  2002-04       Impact factor: 3.825

7.  Head and neck tumors: imaging recurrent tumor and post-therapeutic changes with CT and MRI.

Authors:  M Lell; U Baum; H Greess; A Nömayr; E Nkenke; M Koester; M Lenz; W Bautz
Journal:  Eur J Radiol       Date:  2000-03       Impact factor: 3.528

8.  National Cancer Database report on cancer of the head and neck: 10-year update.

Authors:  Jay S Cooper; Kim Porter; Katherine Mallin; Henry T Hoffman; Randal S Weber; Kian K Ang; E Greer Gay; Corey J Langer
Journal:  Head Neck       Date:  2009-06       Impact factor: 3.147

9.  Development of a new invasion and metastasis model of human oral squamous cell carcinomas.

Authors:  S Kawashiri; S Kumagai; K Kojima; H Harada; E Yamamoto
Journal:  Eur J Cancer B Oral Oncol       Date:  1995-07

10.  MR imaging of phagocytosis in experimental gliomas.

Authors:  C Zimmer; R Weissleder; K Poss; A Bogdanova; S C Wright; W S Enochs
Journal:  Radiology       Date:  1995-11       Impact factor: 11.105

View more
  3 in total

1.  Non-invasive intravital imaging of head and neck squamous cell carcinomas in live mice.

Authors:  Panomwat Amornphimoltham; Jamie Thompson; Nicolas Melis; Roberto Weigert
Journal:  Methods       Date:  2017-08-03       Impact factor: 3.608

2.  Efficient labeling in vitro with non-ionic gadolinium magnetic resonance imaging contrast agent and fluorescent transfection agent in bone marrow stromal cells of neonatal rats.

Authors:  Ying-Qin Li; Ying Tang; Rao Fu; Qiu-Hua Meng; Xue Zhou; Ze-Min Ling; Xiao Cheng; Su-Wei Tian; Guo-Jie Wang; Xue-Guo Liu; Li-Hua Zhou
Journal:  Mol Med Rep       Date:  2015-03-23       Impact factor: 2.952

Review 3.  Iron Oxide as an MRI Contrast Agent for Cell Tracking.

Authors:  Daniel J Korchinski; May Taha; Runze Yang; Nabeela Nathoo; Jeff F Dunn
Journal:  Magn Reson Insights       Date:  2015-10-06
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.